Salarius Pharmaceuticals, Inc. (SLRX) has 26 open-market insider trades by 9 insiders since 2019. The most active filer is Arnold C. Hanish, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| David J. Arthur | CEO | — | 5 | $124K | 2023-02-13 |
| Mark J. Rosenblum | CFOExec VP Finance | — | 6 | $62K | 2025-11-20 |
| Arnold C. Hanish | Dir | — | 7 | $35K | 2025-12-30 |
| William K. McVicar | Dir | — | 2 | $15K | 2023-01-03 |
| Scott Jordan | Chief Business Officer | — | 1 | $10K | 2020-02-18 |
| Bruce J. McCreedy Jr. | Dir | — | 1 | $10K | 2023-01-03 |
| Jonathan P. Northrup | Dir | — | 1 | $10K | 2020-02-11 |
| Tess Burleson | Dir | — | 2 | $10K | 2023-01-03 |
| Jonathan I. Lieber | Dir | — | 1 | $7K | 2023-01-03 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Arnold C. Hanish | Director | Sell | $17 | 2025-12-30 |
| Mark J. Rosenblum | CFO & Exec VP Finance | Buy | $16K | 2025-11-20 |
| Arnold C. Hanish | Director | Buy | $4K | 2025-11-20 |
| Tess Burleson | Director | Buy | $5K | 2022-06-07 |
| Jonathan I. Lieber | Director | Buy | $7K | 2022-06-07 |
| William K. McVicar | Director | Buy | $5K | 2022-06-06 |
Companies that share insiders with SLRX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Arnold C. Hanish | Director | Buy | $5K | 2022-06-03 |
| Mark J. Rosenblum | CFO & Exec VP Finance | Buy | $5K | 2022-05-31 |
| David J. Arthur | CEO | Buy | $8K | 2022-05-26 |
| David J. Arthur | CEO | Buy | $109K | 2022-03-03 |
| Mark J. Rosenblum | CFO & Exec VP Finance | Buy | $30K | 2022-03-03 |
| David J. Arthur | CEO | Buy | $4K | 2021-08-17 |
| Arnold C. Hanish | Director | Buy | $6K | 2021-08-10 |
| Arnold C. Hanish | Director | Buy | $4K | 2020-08-21 |
| David J. Arthur | CEO | Buy | $1K | 2020-08-19 |